MEDISTIA GROUP
The computed 12-month bankruptcy probability of MEDISTIA GROUP is 5.1% (elevated). The 2023 annual accounts show negative equity (€-108k) and a net result of €-118k. Its solvency ranks better than 5% of 10127 sector peers (fiscal year 2023). The company has been active since 2022 and the Belgian State Gazette contains no insolvency signals. The CBE does carry 1 administrative register entry (see administrative flags).
| Equity | €-108k |
| Net result | €-118k |
| Better than sector | 5% |
| Active | 3 yrs |
Mixed profile: strong on profitability, weaker on health.
Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -86.2% | 58.5% | |
| Net result | €-118k | €27k | |
| Equity | €-108k | €52k | |
| Gross operating margin | €-117k | €46k | |
| Total assets | €125k | €107k |
| Fiscal year | 2023 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | €-117k |
| Net profit | €-118k |
| Cash flow | €-117k |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €125k |
| Equity | €-108k |
| Debt | €233k |
| of which ≤ 1y | €229k |
| of which > 1y | €3k |
| Working capital | €-212k |
| Employees (FTE) | - |
| 2023 | |
|---|---|
| Current ratio | 0.08 |
| Quick ratio | 0.08 |
| Working capital ratio | -169.7% |
| Solvency | -86.2% |
| Debt / equity | -2.16 |
| Long-term debt ratio | -0.03 |
| Interest coverage | -4169.35 |
| Gross margin | - |
| Net margin | - |
| ROA | -94.2% |
| ROE | 109.3% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (21 line items)
| Line item | Code | 2023 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €125k |
| Fixed assets | 21/28 | €107k |
| Tangible fixed assets | 22/27 | €60k |
| Financial fixed assets | 28 | €47k |
| Current assets | 29/58 | €18k |
| Amounts receivable within one year | 40/41 | €16k |
| Cash & bank | 54/58 | €1k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €125k |
| Equity | 10/15 | €-108k |
| Contributions / capital | 10/11 | €10k |
| Accumulated profits (losses) | 14 | €-118k |
| Amounts payable | 17/49 | €233k |
| Amounts payable after one year | 17 | €3k |
| Amounts payable within one year | 42/48 | €229k |
| Trade debts payable within one year | 44 | €32k |
| Income statement | ||
| Gross operating margin | 9900 | €-117k |
| Operating result | 9901 | €-118k |
| Financial charges | 65 | €28 |
| Result before taxes | 9903 | €-118k |
| Net result for the period | 9904 | €-118k |
| Result to be appropriated | 9905 | €-118k |
-
Adel DJARAMOUDirectorState Gazette act 25026712 (26-02-2025)Current26-02-2025 → present
Former directors (1)
-
Stéphane MORAINDirectorState Gazette act 25026712 (26-02-2025)Former- → 10-02-2025
| NACE primary | Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies(70200) |
| Legal form | Private limited company(610) |
| Incorporation | 08-12-2022 |
| Status | Active |
| Postal code | - |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21492B0083/00K009 | Brussels | 836 m² | 1 · 965 m² | 21.9 m · 1 fl. |
| 21526D0069/02A005 | Brussels | 310 m² | 1 · 243 m² | 10.9 m · 2 fl. |
| 21002A0123/00Y004 | Brussels | 132 m² | 1 · 132 m² | 14.6 m · 4 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
26-02-2025 1 director appointed, 1 resigning
- Adel DJARAMOU, Bestuurder
- Stéphane MORAIN, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "St\u00E9phane MORAIN",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_dissolution",
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2025-02-10",
"evidence_quote": "Monsieur St\u00E9phane MORAIN fait part \u00E0 l\u0027assembl\u00E9e de sa d\u00E9mission de ses fonctions d\u0027administrateur de la soci\u00E9t\u00E9 \u00E0 compter du 10 f\u00E9vrier 2025.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Adel DJARAMOU",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de nommer en qualit\u00E9 de nouvel administrateur: Adel DJARAMOU",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "administrateur",
"person": {
"rrn": null,
"name": "St\u00E9phane MORAIN",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e prend acte de cette d\u00E9mission et d\u00E9charge l\u0027int\u00E9ress\u00E9 de son mandat pour la gestion exerc\u00E9e jusqu\u0027\u00E0 ce jour.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "administrateur",
"person": {
"rrn": null,
"name": "MEDISTIA GROUP",
"address": "Chauss\u00E9e de Wavre 1341, 1160 Auderghem",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de transf\u00E9rer son si\u00E8ge social \u00E0 l\u0027adresse suivante: Avenue de la libert\u00E9 175 1080 Molembeek",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Wemmel",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-02-26",
"filing_date": "2025-02-10",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2025-02-10",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0794.537.292",
"name_full": "MEDISTIA GROUP",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "St\u00E9phane Morain",
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}01-10-2024 Restructuring of share classes
Technical details
{
"events": [
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "de enige aandeelhouder",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": 400,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "other",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "other",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "other",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "other",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "other",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Charles HUYLEBROUCK",
"firm_city": null,
"firm_name": null,
"office_city": "Brussel",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-10-01",
"filing_date": "2024-09-27",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2024-09-09",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": "2024-09-09"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0794.537.292",
"name_full": "MEDISTIA GROUP",
"legal_form": "Besloten Vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"een uitgifte van de akte",
"de geco\u00F6rdineerde statuten"
],
"shareholders_after": [],
"share_classes_after": []
}31-10-2023 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": null,
"notary": {
"name": "Charles HUYLEBROUCK",
"firm_city": null,
"firm_name": null,
"office_city": "Brussel",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2023-10-31",
"filing_date": "2023-10-27",
"act_kind_objet": "BENAMING, STATUTEN (VERTALING, COORDINATIE, OVERIGE"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2023-10-19",
"unanimous": true
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0794.537.292",
"name": "ZEYO MEDICALE",
"role": "other",
"address": "Avenue des Bouleaux 26, 1780 Wemmel",
"is_foreign": false,
"legal_form": "Besloten Vennootschap",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [
"2:3 WVV"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": null,
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0794.537.292",
"name_full": "ZEYO MEDICALE",
"legal_form": "Besloten Vennootschap"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Charles Huylebrouck",
"org_rep_person_name": null
},
"summary_narrative": "De algemene vergadering van ZEYO MEDICALE heeft eenparig besloten de naam van de vennootschap te wijzigen in \u0022MEDISTIA GROUP\u0022 en de benaming in de statuten aan te passen. Daarnaast is er akte genomen van het ontslag van Laura C\u00E9line VAN DER HOEDEN en de benoeming van Ayyoub ISMAIL als nieuwe bestuurder. De notaris is gemachtigd om de genomen beslissingen uit te voeren en de administratieve formaliteiten te vervullen.",
"co_filed_documents": [
"een uitgifte van de akte",
"de geco\u00F6rdineerde statuten"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "statutes"
}| Legal nameFR | MEDISTIA GROUP |
- 20-06-2025 Address struck